Generex Biotechnology Corporation (Nasdaq: GNBT) signed a definitive agreement with certain accredited investors for the sale of shares of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE